Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed diagnosis of melanoma, based on a tissue sample examined in a lab.
- People who have gone through the full informed consent process and signed a consent form, after having all study requirements and possible risks explained to them.
- People who are able to sit for up to 60 minutes at a time.
Who may not be able to join:
- People who are unable to give informed consent, such as those with a mental condition that makes it difficult to understand what the study involves and what the possible consequences are.
- People with serious ongoing health conditions affecting the heart, liver, brain or nervous system, hormonal system, or other major body systems, where participation could put them at risk or make the study difficult to carry out (confirm with trial site).
- People with a significant or severe infection, whether short-term or ongoing.
- People who are pregnant, breastfeeding, or planning to become pregnant during the study.
- Women who could become pregnant and are not using an effective form of contraception, or who are unwilling or unable to be tested for pregnancy.
- People with a known history of severe, persistent constipation.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ekaterina Galanzha, PhD, Cytoastra
Phone: 5017658175
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identify and count CTCs in blood in vivo
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.